| Nov 30, 2009
Whether you're still plowing through Thanksgiving leftovers or easing back to your normal fare, billions of bacteria in your digestive tract are eagerly awaiting their next meal. And if you feed them well enough, they'll thank you by producing gas....
| Feb 18, 2011
| 3:13 PM
A cardiologist, endocrinologist, psychiatrist, nurse practitioner and allergist. These five medical professionals in Burbank and Glendale may have different specialties, but they have one source of income in common — drug companies.
Since 2009, 33...
| Aug 19, 2010
The safety of most diabetes drugs are time-tested — insulin was discovered in the early 1920s, and two of the other most commonly prescribed, metformin and sulfonylurea, have been around since the 1950s.
Avandia is different. The drug landed with a...
| Sep 30, 2010
| 6:47 AM
(Reuters) - GlaxoSmithKline's herpes vaccine failed to protect women against the virus in a trial, the U.S. National Institutes of Health said Thursday, and the company said it was stopping development of the product.
The test of 8,000 women in the U.S....
| Oct 18, 2010
| 9:13 PM
Follow drug company money in Illinois, and it leads to the psychiatry department at Rush University Medical Center, a prominent headache clinic on the North Side of Chicago, a busy suburban urology practice and a psychiatric hospital accused of...
| Oct 28, 2010
| 7:23 PM
Last week, after the launch of a new database detailing doctors' financial ties with drug companies, Dr. Daniel Carlat sat at his computer and began searching for information about colleagues.
He found several doctors who had potentially compromising...
| Jan 29, 2009
I'm grateful for the opportunity to be here today and present my closing argument and my chance to talk to you and talk to the people of Illinois and talk to anybody else who is listening.
In the last couple of days I've had a chance to be able to go out...
| Jul 13, 2010
| 8:26 AM
GlaxoSmithKline agreed to pay about $460 million to resolve a majority of lawsuits alleging the company's Avandia diabetes drug can cause heart attacks and strokes, people familiar with the accords said.
Glaxo, the U.K.'s biggest drugmaker, agreed to...
| Jun 30, 2010
| 2:11 PM
| Jun 29, 2010
The diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one new study linking it to an increased risk of heart attacks and a separate study linking it to an increased risk of heart failure and stroke....
| Jul 14, 2010
| 12:54 PM
U.S. health advisers said GlaxoSmithKline Plc's GSK.L diabetes drug Avandia should be allowed to stay on the market in some form, easing a threat of further litigation that could have followed a ban.
The 33-member panel of outside experts convened by the...